History
  • No items yet
midpage
United States v. Quality Formulation Laboratories, Inc.
512 F. App'x 237
3rd Cir.
2013
Read the full case

Background

  • In 2010, after a civil suit, the FDA entered a Consent Decree halting Paterson, NJ production by QFL, ASN, SNI and Mohamed Desoky.
  • The Decree required cessation of manufacturing/holding food at Paterson and notification before any ownership or business changes.
  • Paterson facility was shut; manufacturing moved to Congers, NY facility owned by ADH Health Products.
  • FDA alleged criminal contempt for continuing manufacturing at Congers and related actions; defendants argued good-faith reliance on a contract with ADH.
  • Trial resulted in convictions for criminal contempt; Mohamed received 40 months, Ahmad and Omar 34 months each; corporations fined; convictions appealed.
  • The Third Circuit affirmed convictions but vacated and remanded sentences for further factual findings on the sentencing enhancement.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Exclusion of Richardson testimony Prosecution argued it showed intent; admissibility questioned. Evidence of remedial steps could negate willfulness. No abuse; testimony excluded as not probative of charged conduct.
Good faith jury instruction Instructions plausibly supported good faith defense; preferred nuances not included. Instruction on plausibility and false statements misstates defense law. No reversible error; instructions viewed as a correct overall charge.
Sufficiency of evidence for aiding and abetting Omar and Ahmad aided concealment of relocation; sufficient evidence. Insufficient proof of aiding and abetting elements. Evidence sufficient; reasonable jurors could find all elements.
Closing arguments Prosecutor comments improper; affected jury impartiality. Arguments were not prejudicial; objections preserved. No reversible error; statements not shown to prejudice.
Sentencing enhancement under § 3B1.1(b) Omar and Ahmad supervised/criminal organization; enhancement proper. Lacked explicit factual findings on supervision/organization. Remanded for further factual findings; convictions affirmed.

Key Cases Cited

  • United States v. Givan, 320 F.3d 452 (3d Cir. 2003) (abuse-of-discretion review on evidentiary decisions)
  • United States v. Garvin, 565 F.2d 519 (8th Cir. 1977) (evidence of good acts to negate intent admissible in some contexts)
  • United States v. Shavin, 287 F.2d 647 (7th Cir. 1961) (evidence of properly submitted medical bills to show lack of intent)
  • Taberer v. Armstrong World Industries, Inc., 954 F.2d 888 (3d Cir. 1992) (good faith defense plausibility framework)
  • United States v. Gross, 961 F.2d 1097 (3d Cir. 1992) (good faith instruction reiterates government burden to show knowledge and willfulness)
  • United States v. Berrios, 676 F.3d 118 (3d Cir. 2012) (plain-error review for unobjected statements)
  • United States v. Nolan, 718 F.2d 589 (3d Cir. 1983) (aiding and abetting elements and intent)
  • United States v. DeGovanni, 104 F.3d 43 (3d Cir. 1997) (supervisor liability standard under § 3B1.1)
  • United States v. Katora, 981 F.2d 1398 (3d Cir. 1992) (supervisor/organization control analysis)
  • United States v. Grier, 475 F.3d 556 (3d Cir. 2007) (en banc; standard for Guidelines interpretation)
  • United States v. Rivas, 493 F.3d 131 (3d Cir. 2007) (standard for evaluating prosecutorial misconduct)
Read the full case

Case Details

Case Name: United States v. Quality Formulation Laboratories, Inc.
Court Name: Court of Appeals for the Third Circuit
Date Published: Jan 25, 2013
Citation: 512 F. App'x 237
Docket Number: 11-4511, 11-4512, 11-4513
Court Abbreviation: 3rd Cir.